Tag: Featured

CLASP-TR demonstrates significant improvement in tricuspid regurgitation up to one year after procedure.  

Key Points Tricuspid regurgitation is a debilitating valve disorder characterized by shortness…

Wally Omar

Alirocumab initiation after MI associated with lower plasma atheroma volume: PACMAN-AMI

Key Points PCSK-9 inhibitors have emerged as a viable treatment option patients…

Wally Omar

Mavacamten improves LVOT gradients in patients with HCM: EXPLORER-LTE

Key Points: In the EXPLORER-LTE study, patients with severely symptomatic obstructive HCM…

Wally Omar

Vupanorsen shown to effectively decrease non-HDL cholesterol in patients already on statins: TRANSLATE-TIMI 70

Key Points: A need for various lipid-lowering agents to combat high cholesterol…

Wally Omar

Reduction in Lp(a) possible with siRNA therapy: APOLLO

Key Points: In the Phase I APOLLO study, patients without known ASCVD…

Wally Omar

SODIUM-HF: Study Of Dietary Intervention Under 100 Mmol In Heart Failure

Key points: Sodium-HF sought to determine whether dietary sodium reduction reduces the…

Wally Omar

An Old Drug with New Tricks: Tranexamic Acid Decreases Bleeding Events in Surgery, POISE-3 Suggests

Key Points:  Tranexamic acid, given to patients undergoing noncardiac surgery, was associated…

Wally Omar

VALOR-HCM: Treatment with mavacamten decreased need for septal reduction therapy in patients with hypertrophic cardiomyopathy.

Key Points: In the VALOR-HCM study, patients with severely symptomatic obstructive HCM…

Wally Omar

EMPULSE: Empagliflozin improves outcomes in all Heart Failure admissions

Key Points: In the EMPULSE study, patients admitted with acute HF of…

Wally Omar

Icosapent Ethyl Shows Signal but Not Significance for Clinical Improvement in COVID-19 Outpatients – The PREPARE-IT 2 Trial

Key Points: Icosapent ethyl (IPE) had previously shown a signal for improvement…

Wally Omar

Ticagrelor Finds a Quick, Effective Reversal Agent in Bentracimab: REVERSE-IT Early Data

Key Points: To date, P2Y-12 inhibitors do not have a commercially approved…

Wally Omar

AXIOMATIC-TKR: Milvexian a Success for Prevention of Venous Thromboembolism after Elective Knee Arthroplasty

Key Points:  Milvexian is a first-in-class rapidly absorbed oral Factor XIa inhibitor…

Wally Omar

Aspirin Not Proven to Prevent Dementia and Cognitive Impairment – Results of the ASCEND Trial

Key Points: The ASCEND trial sought to determine whether low-dose aspirin could…

Wally Omar

Can Your Fitbit Accurately Detect Atrial Fibrillation? Results of The Fitbit Heart Study

Key Points Wearable technologies have optical photoplethysmography (PPG) sensors to measure heart…

Wally Omar

Canaglifozin associated with Improved Quality of Life, Regardless of Ejection Fraction or Diabetes

CHIEF-HF Key Points: In the CHIEF-HF study, patients with HF of any…

Wally Omar

Avoiding triggers for Atrial Fibrillation has no effect on Quality of Life: results from I-STOP-A-FIB show

Key Points: Interest in this study was generated by patients with atrial…

Wally Omar

EHR-Derived Risk Estimates for Clinicians Do Not Change Heart Failure Patient Outcomes – The REVeAL-HF Trial

Key Points: Previously, the impact of risk prediction on clinical decision-making and…

Wally Omar

Coffee-drinkers rejoice: caffeine consumption not associated with atrial arrhythmias (in young, healthy patients): CRAVE shows

Key Points: Conventional medical wisdom warns against excessive coffee and/or caffeine consumption…

Wally Omar

Multifaceted Interventions Delivered by Rural Physicians Significantly Reduce Hypertension Rates in Rural China: CRHCP

Key Points Rural areas represent particularly vulnerable areas for the control of…

Wally Omar